• Thumbnail for Trastuzumab
    Trastuzumab, sold under the brand name Herceptin among others, is a monoclonal antibody used to treat breast cancer and stomach cancer. It is specifically...
    67 KB (5,977 words) - 19:32, 17 August 2024
  • Thumbnail for Trastuzumab deruxtecan
    Trastuzumab deruxtecan, sold under the brand name Enhertu, is an antibody-drug conjugate consisting of the humanized monoclonal antibody trastuzumab (Herceptin)...
    25 KB (2,086 words) - 02:24, 16 July 2024
  • Thumbnail for Trastuzumab emtansine
    Trastuzumab emtansine, sold under the brand name Kadcyla, is an antibody-drug conjugate consisting of the humanized monoclonal antibody trastuzumab (Herceptin)...
    29 KB (2,696 words) - 14:16, 27 July 2024
  • Pertuzumab/trastuzumab/hyaluronidase, sold under the brand name Phesgo, is a fixed-dose combination medication to treat adults with HER2-positive breast...
    12 KB (966 words) - 04:46, 15 July 2024
  • Trastuzumab/hyaluronidase, sold under the brand name Herceptin SC among others, is a fixed-dose combination medication for the treatment of HER2-overexpressing...
    11 KB (703 words) - 18:13, 27 March 2024
  • Thumbnail for HER2
    antibody trastuzumab (marketed as Herceptin). Trastuzumab is effective only in cancers where HER2 is over-expressed. One year of trastuzumab therapy is...
    43 KB (4,651 words) - 13:41, 27 July 2024
  • Thumbnail for Pertuzumab
    brand name Perjeta, is a monoclonal antibody used in combination with trastuzumab and docetaxel for the treatment of metastatic HER2-positive breast cancer;...
    24 KB (2,275 words) - 00:45, 12 July 2024
  • Thumbnail for Antibody–drug conjugate
    authorization from the European Medicines Agency in October 2012. Trastuzumab emtansine (ado-trastuzumab emtansine or T-DM1, trade name: Kadcyla, marketed by Genentech...
    41 KB (4,305 words) - 11:56, 24 August 2024
  • Thumbnail for Tucatinib
    2021. Tucatinib is a kinase inhibitor indicated in combination with trastuzumab and capecitabine for the treatment of adults with advanced unresectable...
    21 KB (1,685 words) - 05:17, 16 July 2024
  • Thumbnail for Exatecan
    of camptothecin with antineoplastic activity. A derivative is used in Trastuzumab deruxtecan. Abou-Alfa, GK; Letourneau, R; Harker, G; Modiano, M; Hurwitz...
    3 KB (98 words) - 05:18, 1 January 2024